Meeting Details

The 9th Annual General Meeting was convened and held on Friday, 21st August, 2026, from 11:30 A.M. to 12:30 P.M. (IST) at Mercure Hotel, Plot No. 51, Near Tribune Chowk, Industrial Area, Phase II, Chandigarh - 160002. This was the first AGM following the company's listing.

Attendance and Quorum

Six (6) Members/Shareholders were present at the AGM, confirming requisite quorum as prescribed under Section 103 of the Companies Act, 2013. The meeting was attended by Directors, Auditors, Chief Financial Officer, and Company Secretary.

Management Commentary

Mr. Ashish Gulati, Chairman, provided an overview of the company's focus during FY 2025-26 on strengthening pharmaceutical and allied operations while maintaining high standards of regulatory compliance, corporate governance, and sustainable growth.

Financial Performance Highlights

For the financial year ended 31st March, 2026, the company achieved revenue of approximately ₹148 Crore and reported Profit After Tax (PAT) of approximately ₹4.51 Crore. The performance reflected the company's focus on business growth, market expansion, operational efficiency, and sustainable value creation.

Voting Process Details

The Notice along with the Annual Report was circulated to Members on 24th July, 2026. Remote e-voting through NSDL was available from 18th August, 2026 at 9:00 A.M. to 20th August, 2026 at 5:00 P.M. Members whose names appeared in the Register of Members or Register of Beneficial Owners as on 14th August, 2026 were entitled to vote.

Mr. Sahil Malhotra of SV & Associates, Practicing Company Secretaries, was appointed as the Scrutinizer for scrutinizing the voting process. The voting results were to be submitted to the Stock Exchange within two working days of the conclusion of the Meeting and uploaded on the company's website.

Resolutions Considered and Approved

The following six resolutions were taken up for consideration and voting:

1. Ordinary Resolution: To receive, consider and adopt the Audited Standalone Financial Statements for FY ended 31st March, 2026, with Reports of Board of Directors and Auditors

2. Ordinary Resolution: To receive, consider and adopt the Audited Consolidated Financial Statements for FY ended 31st March, 2026, with Report of the Auditors

3. Ordinary Resolution: To re-appoint Ms. Pooja Singh (DIN: 10547745), who retires by rotation and offers herself for re-appointment

4. Ordinary Resolution: Ratification of remuneration of M/s. Balwinder & Associates, Cost Accountants (Firm Registration No. 000201), as Cost Auditor for FY ending 31st March, 2027

5. Special Resolution: Alteration in the Object Clause of the Memorandum of Association

6. Special Resolution: Approval for incorporation and investment in subsidiary company(ies) in India

Meeting Conclusion

The Board recommended all resolutions for approval. Members raised questions and suggestions which were addressed by the Chairman/Management. The meeting concluded at 12:30 P.M. with a vote of thanks proposed by Mr. Ankit Kapoor, Company Secretary & Compliance Officer.